NCT02372253View on ClinicalTrials.gov

Verapamil for Beta Cell Survival Therapy in Type 1 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2019

Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG

Verapamil

DRUG

Placebo

Trial Locations (1)

35233

University of Alabama at Birmingham, Birmingham

Sponsors
All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

University of Alabama at Birmingham

OTHER